Komipharm International Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	27,888	12,448	14,820	10,805	11,992
Short-Term Investments	-0	0	-0	-	23.08
Trading Asset Securities	-	10,000	-	-	1,914
Cash & Short-Term Investments	27,888	22,448	14,820	10,805	13,929
Cash Growth	24.23%	51.47%	37.16%	-22.43%	-18.57%
Accounts Receivable	17,323	15,696	12,042	10,849	9,858
Other Receivables	8.92	1.34	47.67	25.07	150.49
Receivables	22,969	21,808	17,901	13,984	12,848
Inventory	15,184	14,566	14,901	16,254	14,176
Prepaid Expenses	392.44	181.04	1,723	327.35	183.49
Other Current Assets	2,054	932.06	667.43	221.76	315.9
Total Current Assets	68,487	59,935	50,012	41,593	41,452
Property, Plant & Equipment	55,824	55,784	64,239	66,522	70,141
Long-Term Investments	631.54	1,010	2,619	1,223	2,220
Other Intangible Assets	1,688	1,841	42.46	54.76	62.17
Long-Term Accounts Receivable	-	-	-	-	0
Long-Term Deferred Charges	3,900	2,052	1,172	753.46	847.1
Other Long-Term Assets	3,332	2,128	470.07	1,579	539.54
Total Assets	133,915	122,767	118,598	111,751	115,262
Accounts Payable	4,864	5,385	2,615	3,746	2,756
Accrued Expenses	362.53	309.88	437.59	274.77	329.23
Short-Term Debt	27,797	33,719	36,731	21,500	19,500
Current Portion of Long-Term Debt	5,545	829.46	3,531	13,141	731.05
Current Portion of Leases	203.67	185.04	245.64	174.68	154.46
Other Current Liabilities	13,980	5,805	8,668	2,211	2,213
Total Current Liabilities	52,752	46,233	52,228	41,047	25,685
Long-Term Debt	6,810	8,896	4,326	3,057	12,798
Long-Term Leases	315.96	209.6	267.91	258.85	237.84
Long-Term Deferred Tax Liabilities	1,854	1,761	1,761	1,741	1,741
Other Long-Term Liabilities	125.93	129.27	0	0	2,394
Total Liabilities	61,858	57,229	58,583	46,104	42,856
Common Stock	7,376	7,062	7,060	6,419	6,419
Additional Paid-In Capital	85,835	69,115	73,874	80,279	78,807
Retained Earnings	-17,879	-10,670	-23,783	-24,804	-18,290
Treasury Stock	-8,609	-5,730	-2,052	-1,989	-989.46
Comprehensive Income & Other	2,816	2,504	1,238	725.91	513.98
Total Common Equity	69,539	62,280	56,338	60,631	66,460
Minority Interest	2,519	3,257	3,677	5,016	5,946
Shareholders' Equity	72,057	65,538	60,015	65,647	72,406
Total Liabilities & Equity	133,915	122,767	118,598	111,751	115,262
Total Debt	40,672	43,839	45,102	38,131	33,422
Net Cash (Debt)	-12,785	-21,391	-30,282	-27,327	-19,493
Net Cash Per Share	-180.89	-306.68	-431.66	-388.82	-277.38
Filing Date Shares Outstanding	71.64	69.28	70.15	70.12	70.28
Total Common Shares Outstanding	71.64	69.28	70.15	70.12	70.28
Working Capital	15,734	13,702	-2,217	545.11	15,768
Book Value Per Share	970.63	898.99	803.07	864.66	945.70
Tangible Book Value	67,850	60,439	56,295	60,576	66,398
Tangible Book Value Per Share	947.07	872.41	802.46	863.88	944.81
Land	14,149	14,149	17,998	17,903	18,678
Buildings	42,228	42,177	44,444	44,337	44,359
Machinery	27,540	26,410	25,514	25,146	24,625
Construction In Progress	10,952	9,894	10,804	10,719	10,719

Source: S&P Global Market Intelligence. Standard template. Financial Sources.